BAILEE POPE: Open Payments
NPI 1033834411 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$152 in 6 payments from 3 companies in 2025. Trend: 2023 $1,479 · 2024 $319 · 2025 $152
Food & beverage: $152
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $78 |
| Gilead Sciences, Inc. | 2 | $50 |
| Celgene Corporation | 1 | $24 |
Products named: KISQALI, Trodelvy, REBLOZYL, Fabhalta.
Industry payments across KY — which companies pay providers there.
